NIES ALAN S
SEC CIK 1270260 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Dir | 41.0K | — | — | 2 | 2022-04-30 | 2023-05-21 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
NIES ALAN S made no open-market trades at LXRX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-22 | 2023-05-21 | LXRX | LEXICON PHARMACEUTICALS, INC. | NIES ALAN S | Dir | M - OptEx | $0.00 | +9,302 | 41.0K | +29% | $0 |
| D | 2022-05-02 | 2022-04-30 | LXRX | LEXICON PHARMACEUTICALS, INC. | NIES ALAN S | Dir | M - OptEx | $0.00 | +4,024 | 31.7K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations